IP in Healthcare 2017 Conference

June 2017

London & Manchester

Join us for the latest updates on intellectual property issues in the pharmaceuticals, life sciences, and medical device sectors at HGF's annual IP in Healthcare conference.

Tuesday 6th June

Royal Academy of Chemistry, Burlington House, Piccadilly, London, W1J 0BA

Tuesday 13th June

Citylabs, Nelson St, Manchester M13 9NQ

Registration from 08.45am. Last session finishes at 1.25pm followed by lunch. 

To register for FREE please email Liz Renn or call +44(0) 133 233 0189.


To view and download the full programme please click here


Be confident about confidential information 

Almost all businesses in the healthcare sector rely on the protection given to confidential information but it is often misunderstood. Properly regulated, it is a valuable IP asset and all businesses should have systems for identifying, recording and protecting their trade secrets. This session will review what can be classed as confidential information, how to identify, capture and protect it and the commercial benefits. Speaker: Michelle Davies


Europe takes centre stage: The impact of the Unitary Patent and Unified Patent Court

The European patent system is due to see its biggest change in a generation. On present estimates, the UPC looks like it will be ready to open in December 2017, or early 2018 which will see the introduction of a new pan-European court and patent. We will examine how the new system will work and strategies for dealing with existing and future patents. Speaker: Martyn Fish


How ingestibles and implantables have moved from Sci–Fi to the real world 

Ingestibles and implantables are one evolving trend set to revolutionise healthcare as we know it. Once in the realm of science fiction, companies are now actively filing patents to protect innovations in this area. We will look at the emerging trends and consider potentially patentable aspects of software platforms and program applications used to aggregate and analyse the health data. Speakers:  Dr Susan Keston and Sarah Rodriguez


Patenting medical methods 

In EPC 2000, which came into effect on 13 December 2007, Art 53 EPC changed the basis for exclusion of certain inventions in the medical field. Nearly ten years on there is now greater clarity to the exclusions. This session will review how practice has developed and what the exclusions mean in practical scenarios and how they can be avoided. Speaker: Vanessa Stainthorpe 


Formulating patent protection for delivering actives 

Finding an active compound for a therapy is the first step in bringing a product to market. In some cases the active compound can be administered simply, however this is often not possible, and a promising active compound can fail without a formulated solution. We will discuss features of a formulation that might provide patentable subject matter and some practical implications.  Speaker: Dr Stewart Eccles


A case law update in the Healthcare industry 

This session will provide a case law update in the healthcare industry with a focus on interesting cases relating to inherent registerability, an international case round up and a review of the Glaxo v Sandoz case study. Speakers: Stephanie Loeffler-Reading, Jonathan Thurgood and Katie Goulding


Managing risks for the launch of a product in an aggressive market 

Launching a new product into the marker can be frightening, especially when that market is dominated by large aggressive competitors. However, there are tactics and strategies to help identify risks and, to minimise and manage those risks. This session covers basic checks and actions that can be completed before launch. Speakers: Martyn Fish and Martin Connors


 Protection and commercialisation of diagnostics and personalised medicine 

Diagnostic tests are an important tenet of healthcare provision, and the development of “personalised medicine” is a major focus in the improvement of healthcare.  This session will review the current challenges in patenting diagnostics and strategies to negotiate them, and companion diagnostic deals and the issues driving and impacting on negotiations. Speakers: Janet Knowles and Douglas Drysdale


To view the full programme please click here


To register for FREE please email Liz Renn or call +44(0) 133 233 0189. 



About HGF's Healthcare team

The HGF Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in healthcare fields of biotechnology, pharmaceuticals and medical technologies.  

HGF has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights. 

The team offers the full range of IP services including:

  • IP strategy and advice;
  • Patent and trade mark procurement;
  • IP portfolio management;
  • Freedom-to-operate advice and opinions;
  • IP due diligence assessments and opinions;
  • Supplementary protection certificates (SPC's) and data exclusivity advice;
  • IP licenses and agreements;
  • IP disputes management and litigation